Biology
Pain Pathways and Nociceptor Sensitization in Chronic Pain
Quick fact
Chronic pain affects over 20% of adults worldwide, and in many cases, the original tissue injury has healed—yet the brain still receives exaggerated pain signals because the nociceptors have become 'tuned' to fire more easily.
Why this is interesting
We all know pain is a warning signal, but why does it sometimes persist long after an injury has healed? What changes in the nervous system to turn a protective alarm into a chronic condition that seems to have no off switch?
Read the full explanation
Understanding Pain Pathways and Nociceptor Sensitization in Chronic Pain
Imagine you touch a hot stove. Specialized nerve endings called nociceptors in your skin detect the extreme temperature and send a rapid electrical signal up your spinal cord to your brain. This is acute pain—a clear, sharp warning that you are damaging tissue. Normally, once the stove is removed, the pain fades quickly. However, in chronic pain, this alarm system fails to reset. To understand why, think of pain as a volume knob. Acute pain is like turning the knob to a low or moderate level—just enough to get your attention. In chronic pain, that knob gets stuck turned up high. Even light touch, which shouldn't hurt, can now trigger pain. This is called allodynia. A pinch that would normally be unpleasant becomes intensely painful—hyperalgesia. The change happens because nociceptors can become sensitized. This means they respond more vigorously to stimuli and even fire spontaneously. The sensitization occurs at two levels: at the site of injury (peripheral sensitization) and in the spinal cord and brain (central sensitization). Once sensitization is established, the pain pathway itself is altered, so that even normal signals from touch receptors can contribute to the perception of pain.
A deeper explanation
How does sensitization work? When tissue is injured or inflamed, immune cells release chemical mediators like prostaglandins, bradykinin, and nerve growth factor. These molecules bind to receptors on nociceptor terminals, triggering intracellular signaling cascades that lower the threshold for activation. For example, phosphorylation of sodium channels makes them open more easily, so less stimulation is needed to generate an action potential. This is peripheral sensitization. But the problem doesn’t stop there. That barrage of action potentials travels to the dorsal horn of the spinal cord, where nociceptor neurons synapse with second-order neurons. The repetitive firing causes the release of neurotransmitters—glutamate and substance P. Substance P binds to neurokinin receptors, while glutamate activates NMDA receptors. Normally NMDA receptors are blocked by a magnesium ion, but when the neuron is strongly depolarized, the magnesium is expelled, allowing calcium to flood in. This triggers a cascade that strengthens the synapse—a process called long-term potentiation. This is the essence of central sensitization. Once central sensitization occurs, the spinal cord neurons become hyperresponsive. Even input from non-painful touch fibers (A-beta fibers) can now activate pain pathways. This explains why a gentle breeze can feel excruciating in certain chronic pain conditions. The brain itself also undergoes plastic changes, expanding representation of the painful area in the somatosensory cortex and altering descending modulatory systems (which normally inhibit pain). These descending pathways can become impaired, meaning the brain's natural pain-suppressing mechanisms are less effective. Understanding this mechanism is crucial: it reveals that chronic pain is not a symptom but a disease of the nervous system. It explains why drugs that simply block pain acutely (like NSAIDs) often fail in chronic pain—they don't correct the sensitized state. Targeting central sensitization (e.g., with NMDA antagonists or gabapentinoids) or promoting descending inhibition (e.g., with certain antidepressants) offers better therapeutic strategies.